Journal of Biological Engineering, published by BMC, stands as a prominent Open Access journal since 2007, dedicated to advancing the interdisciplinary field of biological engineering. With an ISSN of 1754-1611, this UK-based journal aims to provide a platform for researchers and professionals to disseminate innovative and impactful research across various domains including Biomedical Engineering, Environmental Engineering, Cell Biology, and Molecular Biology. The journal's notable rankings in the 2023 category quartiles exemplify its position within the scientific community, featuring Q2 status in Biomedical Engineering and Environmental Engineering, along with Q3 in Cell Biology and Q2 in Molecular Biology. By maintaining robust Scopus rankings and ensuring free access to cutting-edge research, the Journal of Biological Engineering plays a crucial role in driving discovery and collaboration among scholars, thereby enriching both the academic landscape and applied sciences.

Annual Review of Biochemistry is a premier publication in the field of biochemistry, renowned for its comprehensive and critical reviews that collate significant advancements and insights since its inception in 1946. Published by Annual Reviews in the United States, this journal maintains a prestigious position within the academic community, boasting a Q1 ranking in the biochemistry category for 2023, with an impressive Scopus rank of #4 out of 438, placing it in the top 1% of its field. With a commitment to excellence, it serves as an essential resource for researchers, professionals, and students striving to stay at the forefront of biochemical research. While the journal does not operate on an open-access model, it continues to provide key insights and knowledge that fuel innovation and discovery in the life sciences. As it converges research from various eras up to 2024, Annual Review of Biochemistry remains a vital contributor to the development of molecular biology and genetics, catering to the needs of a diverse readership keen on advancing their understanding and expertise in biochemistry.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, published by Elsevier, serves as a pivotal journal in the fields of biochemistry and biophysics, with a long-standing history dating back to 1956. This esteemed publication, bearing the ISSN 0304-4165 and E-ISSN 1872-8006, continuously contributes to advancing our understanding of complex biological processes through rigorous research articles and reviews. It notably holds a distinguished position with a Q2 classification in Biochemistry and a Q1 ranking in Biophysics for 2023, reflecting its high relevance and impact within these scientific domains. The journal is also recognized within the Scopus metrics, taking a rank of #40 out of 152 in Biophysics and #173 out of 438 in Biochemistry, thus placing it in the 74th and 60th percentiles respectively. Academics and professionals in the life sciences will find this journal an essential resource for current research, cutting-edge techniques, and comprehensive reviews aimed at enhancing the understanding of biological functions. While BIOCHIMICA ET BIOPHYSICA ACTA is not an open-access journal, it remains a cornerstone publication for those seeking to stay at the forefront of biochemical and biophysical research.

Current Research in Biotechnology is a leading journal published by Elsevier, dedicated to the dissemination of high-quality research in the rapidly evolving field of biotechnology. With an ISSN of 2590-2628, this journal has garnered a reputation for its insightful contributions, currently holding a prestigious Q2 ranking in the Biotechnology category, and placing in the 66th percentile within the Scopus rankings for Biochemistry, Genetics, and Molecular Biology. Running from 2019 and set to continue through 2024, the journal aims to provide a platform for groundbreaking studies that advance our understanding and application of biotechnological innovations. Although it operates under a subscription model, the journal ensures that research impacts a wide audience, facilitating collaboration among researchers, professionals, and students across the globe. By focusing on a diverse range of topics within biotechnology, Current Research in Biotechnology is committed to cultivating a vibrant discourse and fostering advancements that address critical challenges in health, agriculture, and environmental sustainability.

Current Opinion in Systems Biology is an esteemed academic journal published by ELSEVIER, focusing on the dynamic and interdisciplinary field of systems biology. Since its inception in 2017, the journal has made significant strides in disseminating cutting-edge research and innovative perspectives across various domains, including applied mathematics, biochemistry, and drug discovery. With an impressive impact factor reflecting its prominent position as a Q1 journal in multiple categories—including Applied Mathematics, Biochemistry, and Computer Science Applications—it serves as a vital resource for researchers, professionals, and students alike. The journal embraces a comprehensive approach to understanding complex biological systems, fostering a deeper insight into the interactions within biological and computational frameworks. This makes it an essential conduit for advancing knowledge and innovation in systems biology, facilitating the development of new methodologies that could lead to groundbreaking discoveries.

BIOSYSTEMS is a prestigious academic journal published by Elsevier Science Ltd, dedicated to the interdisciplinary fields of applied mathematics, biochemistry, genetics, molecular biology, medicine, modeling and simulation, and statistics and probability. Established in 1967, this journal has carved a niche in presenting innovative research that bridges theoretical and practical aspects of biological systems, making it essential reading for researchers, professionals, and students alike. With a robust impact factor and a Q3 category ranking across various fields, BIOSYSTEMS is recognized for its contributions to advancing scientific knowledge and fostering collaborations among disciplines. The journal's rigorous peer-review process ensures high-quality and impactful articles that address complex biological challenges through quantitative and qualitative methods. As a vital resource for the academic community, BIOSYSTEMS invites submissions that enhance understanding of biosystem processes, enabling readers to stay at the forefront of research trends and applications.

TRENDS IN BIOTECHNOLOGY, published by CELL PRESS, stands as a premier journal since its inception in 1983, focusing on the dynamic and ever-evolving fields of bioengineering and biotechnology. With a notable impact factor and ranking in the top quartile (Q1) of its categories for 2023, this journal is recognized for its contribution to advancing scientific knowledge, boasting a Scopus rank of #5/311 in Biotechnology and #5/162 in Bioengineering, placing it in the 98th and 97th percentiles, respectively. Although it does not operate under an open access model, TRENDS IN BIOTECHNOLOGY ensures a rigorous peer-review process that provides a platform for high-quality research that influences both academic and industrial advancements. The journal's objectives encompass the dissemination of cutting-edge research findings, reviews, and insights that foster innovation in biotechnological applications, making it an invaluable resource for researchers, professionals, and students alike. With its broad scope across the intersection of biosciences and technology, TRENDS IN BIOTECHNOLOGY continues to lead discussions and developments that shape the future of the biotechnology landscape.

Cell Systems is an esteemed journal published by CELL PRESS, dedicated to advancing the field of systems biology and its applications in cell biology, histology, and pathology. Since its inception in 2015, it has quickly ascended to a prominent position within the academic community, currently holding a Q1 ranking across multiple categories including Cell Biology, Histology, and Pathology and Forensic Medicine for 2023. With an impressive Scopus ranking—third in Medicine: Pathology and Forensic Medicine, and similarly high standing in Histology—it serves as a key resource for researchers and professionals aiming to explore and disseminate cutting-edge research findings. The journal provides an open-access platform, making it an accessible source of knowledge for students and scholars alike, fostering collaboration and innovation within the dynamic landscape of cellular research. With a commitment to high-quality and impactful publications, Cell Systems plays a pivotal role in shaping the future of biological sciences.

Biotechnology for Biofuels, published by BMC in the United Kingdom, stands at the forefront of renewable energy research. As an open-access journal since 2008, it has become a critical platform for sharing innovative research and developments in the field of applied microbiology and biotechnology, particularly in the sustainable production of biofuels. With an impressive 2023 ranking of Q1 in multiple categories—including Applied Microbiology and Biotechnology, Biotechnology, and Management, Monitoring, Policy and Law—this journal offers unparalleled visibility and accessibility for your work. Its Scopus metrics underscore its influence, with rankings in the top 10% across several categories, emphasizing its integral role in advancing research on environmental sustainability and bioenergy solutions. Researchers, professionals, and students alike will find in this journal a rich resource for current studies, methodologies, and policies essential for navigating the complex landscape of biofuel technology.

CURRENT PROTEIN & PEPTIDE SCIENCE, published by Bentham Science Publishers, is a pivotal journal dedicated to the dynamic and rapidly evolving fields of protein and peptide research. With an ISSN of 1389-2037 and an E-ISSN of 1875-5550, this esteemed journal serves as a platform for disseminating cutting-edge findings from various disciplines, including biochemistry, cell biology, and molecular biology. Recognized for its influence with a 2023 Scopus ranking placing it within the top quartiles of its categories—Q3 in Biochemistry, Q4 in Cell Biology, and Q2 in Medicine—the journal not only enhances the visibility of critical research but also supports the academic community in advancing our understanding of the molecular foundations of life. Established in 2000 and running through 2024, CURRENT PROTEIN & PEPTIDE SCIENCE is positioned to cater to the interests of researchers, professionals, and students alike, providing them with open access to vital knowledge that fuels innovation and scientific inquiry in the United Arab Emirates and beyond.